Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 49 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 33 | 1,688−5.7%/yr | −5.7%/yr | 4.11.3× | 1% | 1,840 in 2030+1.4%/yr |
| Lumbar fusion | 34 | 1,416−0.7%/yr | −0.7%/yr | 3.41.3× | 6% | 1,630 in 2030+2.3%/yr |
| Kyphoplasty & vertebroplasty | 15 | 1,030−5.7%/yr | −5.7%/yr | 2.51.9× | 11% | 920 in 2030−1.8%/yr |
| Cervical fusion & disc arthroplasty | 11 | 616−1.8%/yr | −1.8%/yr | 1.51.1× | 0% | 710 in 2030+2.5%/yr |
| SI joint fusion | 5 | 149+26%/yr | +26%/yr | 0.31.7× | 50% | 80 in 2030−9.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 127 | 31,213+3%/yr | +3%/yr | 74.90.9× | 34% | 43,000 in 2030+5.5%/yr |
| Skin substitutes & wound grafts | 36 | 8,726+10%/yr | +10%/yr | 16.12.2× | 71% | 13,300 in 2030+7.2%/yr |
| Bone graft & orthobiologics | 6 | 241−8.6%/yr | −8.6%/yr | 0.60.9× | 0% | 210 in 2030−2.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 57 | 3,413+4%/yr | +4%/yr | 8.20.9× | 46% | 4,450 in 2030+4.5%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 14 | 652+2.5%/yr | +2.5%/yr | 1.51.4× | 52% | 990 in 2030+7.2%/yr |
| Spinal cord & DRG stimulation | 19 | 505−4.3%/yr | −4.3%/yr | 1.21.7× | 38% | 660 in 2030+4.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 13 | 2,258−6.3%/yr | −6.3%/yr | 5.41.3× | 53% | 2,010 in 2030−1.9%/yr |
| Dialysis access | 17 | 1,438−10%/yr | −10%/yr | 3.60.8× | 63% | 1,570 in 2030+1.4%/yr |
| Superficial venous ablation | 15 | 766−21%/yr | −21%/yr | 1.80.5× | 38% | 870 in 2030+2.2%/yr |
| Carotid revascularization | 16 | 530−3.8%/yr | −3.8%/yr | 1.31.1× | 0% | 600 in 2030+2%/yr |
| Thrombectomy, IVC filters & venous stents | 2 | 454+4.3%/yr | +4.3%/yr | 1.10.8× | 0% | 920 in 2030+12%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 178−7.8%/yr | −7.8%/yr | 0.40.9× | 0% | 160 in 2030−1.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 27 | 2,322−2.7%/yr | −2.7%/yr | 6.01.0× | 12% | 2,400 in 2030+0.5%/yr |
| Cholecystectomy & appendectomy | 50 | 1,841−5.1%/yr | −5.1%/yr | 4.61.1× | 5% | 1,870 in 2030+0.2%/yr |
| Colorectal resection | 4 | 782−3.5%/yr | −3.5%/yr | 2.01.1× | 0% | 730 in 2030−1.1%/yr |
| Antireflux & hiatal hernia surgery | 4 | 304−0.4%/yr | −0.4%/yr | 0.81.0× | 0% | 450 in 2030+6.7%/yr |
| Breast reconstruction | 0 | 213−7.1%/yr | −7.1%/yr | 0.51.3× | 39% | 160 in 2030−4.9%/yr |
| Bariatric surgery | 1 | 105−14%/yr | −14%/yr | 0.31.3× | 0% | 60 in 2030−7.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 44 | 2,107−0.8%/yr | −0.8%/yr | 5.21.0× | 20% | 2,660 in 2030+4%/yr |
| BPH procedures | 37 | 2,068−4.1%/yr | −4.1%/yr | 5.11.1× | 37% | 1,920 in 2030−1.3%/yr |
| Incontinence, prolapse & sacral neuromodulation | 15 | 1,028−2.4%/yr | −2.4%/yr | 2.51.1× | 21% | 990 in 2030−0.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 14 | 868−1.5%/yr | −1.5%/yr | 2.30.8× | 11% | 890 in 2030+0.4%/yr |
| Prostatectomy & nephrectomy | 10 | 583−1.8%/yr | −1.8%/yr | 1.51.1× | 0% | 720 in 2030+3.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 30 | 2,753+4.9%/yr | +4.9%/yr | 6.92.0× | 81% | 4,320 in 2030+7.8%/yr |
| Cochlear implants | 5 | 140+40%/yr | +40%/yr | 0.31.9× | 0% | 220 in 2030+7.8%/yr |
| Sleep apnea & airway implants | 5 | 135+70%/yr | +70%/yr | 0.31.6× | 0% | 140 in 2030+0.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 31 | 2,002−2.5%/yr | −2.5%/yr | 5.20.7× | 34% | 2,170 in 2030+1.4%/yr |
| Tumor & fibroid embolization | 3 | 164+3.8%/yr | +3.8%/yr | 0.40.8× | 65% | 580 in 2030+24%/yr |
| Tumor ablation | 2 | 1340%/yr | 0%/yr | 0.31.0× | 0% | 320 in 2030+15%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 76 | 13,034+33%/yr | +33%/yr | 31.91.1× | 84% | 23,200 in 2030+10%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| LAA occlusion & loop recorders | 56 | 2,663+15%/yr | +15%/yr | 6.02.1× | 5% | 4,850 in 2030+10%/yr |
| Pacemaker, ICD & CRT implantation | 48 | 2,322−5%/yr | −5%/yr | 5.91.1× | 13% | 2,470 in 2030+1%/yr |
| EP ablation | 27 | 1,645+7.2%/yr | +7.2%/yr | 3.61.2× | 0% | 2,880 in 2030+9.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 59 | 2,634−7.4%/yr | −7.4%/yr | 5.71.0× | 6% | 3,030 in 2030+2.3%/yr |
| Structural heart (TAVR, TEER) | 30 | 866+1.2%/yr | +1.2%/yr | 1.91.1× | 0% | 1,110 in 2030+4.2%/yr |
| Mechanical circulatory support | 1 | 186+0.2%/yr | +0.2%/yr | 0.50.7× | 0% | 360 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| DBS & VNS | 3 | 294+5.3%/yr | +5.3%/yr | 0.72.2× | 0% | 570 in 2030+12%/yr |
| Stroke thrombectomy | 8 | 152+1.4%/yr | +1.4%/yr | 0.40.9× | 0% | 110 in 2030−5.6%/yr |
| Aneurysm & intracranial embolization | 5 | 146+15%/yr | +15%/yr | 0.40.8× | 0% | 210 in 2030+6.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 67 | 23,142−1.6%/yr | −1.6%/yr | 56.60.8× | 78% | 24,400 in 2030+0.9%/yr |
| Vitreoretinal surgery | 18 | 1,141−5.2%/yr | −5.2%/yr | 2.81.2× | 60% | 1,150 in 2030+0.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 167 | 36,685−2%/yr | −2%/yr | 93.10.8× | 28% | 39,000 in 2030+1%/yr |
| Bronchoscopy & lung nodule | 20 | 1,248+4.7%/yr | +4.7%/yr | 3.10.8× | 0% | 2,190 in 2030+9.8%/yr |
| ERCP & endoscopic ultrasound | 10 | 846−4%/yr | −4%/yr | 2.10.5× | 2% | 840 in 2030−0.2%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.